Mark Laurenzi
Chief Administrative Officer at Aro Biotherapeutics Co.
Network origin in Mark Laurenzi first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Aro Biotherapeutics Co.
 Aro Biotherapeutics Co. BiotechnologyHealth Technology Aro Biotherapeutics Co. operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics products. It specializes in oncology, drug discovery, drug development, licensing, drug delivery, sirna, immunology, bispecifics, protein conjugation, protein therapeutics and protein engineering services. The company was founded by Karyn O?Neil and Susan Dillon in 2018 and is headquartered in Philadelphia, PA.
10
| Holding Company | Biotechnology | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mark Laurenzi via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Director of Finance/CFO Director/Board Member | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Director/Board Member | |
| BAVARIAN NORDIC A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| INSMED INCORPORATED | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| REVOLUTION MEDICINES, INC. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
Context Therapeutics LLC
 Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Personal Genome Diagnostics, Inc.
 Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | Biotechnology | Director/Board Member | |
Cowen Investment Management LLC
 Cowen Investment Management LLC Investment ManagersFinance Cowen Investment Management LLC (Cowen Investment Management) is a venture capital subsidiary of Cowen, Inc. founded in 1997. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
| ORCHARD THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
| ONCORUS, INC. | Biotechnology | Director/Board Member | |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Investment Managers | Private Equity Investor | |
HealthCare Ventures LLC
 HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures LLC (HealthCare Ventures) is a venture capital firm founded in 1985 by Harold R. Werner. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
FerroKin BioSciences, Inc.
 FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology FerroKin BioSciences, Inc. offers clinical stage biotechnology services for iron chelator in the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemia. The company was founded by Hugh Young Rienhoff, Jr. in 2007 and is headquartered in San Carlos, CA. | Pharmaceuticals: Major | Director/Board Member | |
Neuron23, Inc.
 Neuron23, Inc. Miscellaneous Commercial ServicesCommercial Services Neuron23, Inc. is a clinical-stage biotechnology company based in an undisclosed location. The American company's focus areas are neurodegenerative diseases, neuroinflammatory diseases, and systemic autoimmune and inflammatory diseases. Neuron23 combines recent advances in human genetics with a state-of-the-art drug discovery and biomarker platform using advanced techniques in machine learning and artificial intelligence to advance therapeutics for devastating diseases. The company was founded by Adam Knight and Nancy E. Stagliano has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director/Board Member | |
Altimmune UK Ltd.
 Altimmune UK Ltd. BiotechnologyHealth Technology Altimmune UK Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
| University of Lund | College/University | Doctorate Degree | |
NodThera Ltd.
 NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | Biotechnology | Director/Board Member | |
| PLIANT THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Escient Pharmaceuticals, Inc.
 Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
| REPARE THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree | |
Cantor Fitzgerald & Co.
 Cantor Fitzgerald & Co. Investment Banks/BrokersFinance Cantor Fitzgerald & Co. is the investment bank and brokerage subsidiary of CFS CF & Co. I Holdings LP, which is owned by Cantor Fitzgerald LP in the US. The firm was founded by Bernie Gerald Cantor and John Fitzgerald in 1945. Headquartered in New York City, Cantor Fitzgerald offers clients a global, multi-asset prime brokerage platform with a focus on the quality middle market. | Investment Banks/Brokers | Corporate Officer/Principal | |
| Shipley Raidy Capital Partners | Founder | ||
| K2X TECHNOLOGY & LIFE SCIENCE, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| VAXART, INC. | Biotechnology | Director/Board Member | |
| Watershed Medical, Inc. | Director/Board Member | ||
| WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
Visgenx, Inc.
 Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
| HUNTSWORTH PLC | Miscellaneous Commercial Services | Director/Board Member | |
| Wyeth Vaccines Research | Chief Executive Officer | ||
| Sellinger School of Business & Management | College/University | Masters Business Admin | |
| GSK PLC | Pharmaceuticals: Major | Director/Board Member | |
| Centeon LLC | Corporate Officer/Principal | ||
The American National Red Cross
 The American National Red Cross Medical/Nursing ServicesHealth Services The American National Red Cross provides blood collections and disaster relief services. The firm provides neutral humanitarian care to the victims of war, emergency assistance, disaster relief and education. It offers compensate services such as support and comfort for military members and their families, the collection, processing and distribution of blood products, educational programs that promote health and safety, and international relief and development programs. The company was founded by Clarissa Harlowe Barton in 1881 and is headquartered in Washington, DC. | Medical/Nursing Services | Corporate Officer/Principal | |
Wyeth Lederle Vaccines SA
 Wyeth Lederle Vaccines SA Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Wyeth Lederle Vaccines SA develops and manufactures pharmaceutical products. The company is based in Louvain-la-Neuve, Belgium. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
Bavarian Nordic GmbH
 Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | Biotechnology | Director/Board Member | |
PureSight Advisory LLC
 PureSight Advisory LLC Packaged SoftwareTechnology Services PureSight Advisory LLC provides management software solutions. The private company is based in Newark. | Packaged Software | Director/Board Member |
Statistics
International
| United States | 37 |
| United Kingdom | 6 |
| Sweden | 4 |
| Denmark | 2 |
| Canada | 2 |
Sectoral
| Health Technology | 29 |
| Finance | 7 |
| Consumer Services | 5 |
| Commercial Services | 3 |
| Health Services | 3 |
Operational
| Director/Board Member | 101 |
| Independent Dir/Board Member | 23 |
| Corporate Officer/Principal | 22 |
| Chief Executive Officer | 11 |
| Chairman | 11 |
Most connected contacts
| Insiders | |
|---|---|
| Chris Mirabelli | 29 |
| Bruce Peacock | 28 |
| Elizabeth Anderson | 25 |
| Elaine Heron | 23 |
| Marten Steen | 21 |
| Raidy Kevin J. | 17 |
| Scott Greenberg | 2 |
| Susan Dillon | 1 |
| Karyn O’Neil | 1 |
| Adam Dinerman | 1 |
- Stock Market
- Insiders
- Mark Laurenzi
- Company connections
